2022-11-012023-10-312023-10-31false05951279GILCO CORPORATION LIMITED2024-07-27iso4217:GBPxbrli:pure059512792022-11-01059512792023-10-31059512792022-11-012023-10-31059512792021-10-01059512792022-10-31059512792021-10-012022-10-3105951279bus:SmallEntities2022-11-012023-10-3105951279bus:AuditExempt-NoAccountantsReport2022-11-012023-10-3105951279bus:FullAccounts2022-11-012023-10-3105951279bus:PrivateLimitedCompanyLtd2022-11-012023-10-3105951279core:WithinOneYear2023-10-3105951279core:AfterOneYear2023-10-3105951279core:WithinOneYear2022-10-3105951279core:AfterOneYear2022-10-3105951279core:ShareCapital2023-10-3105951279core:SharePremium2023-10-3105951279core:RevaluationReserve2023-10-3105951279core:OtherReservesSubtotal2023-10-3105951279core:RetainedEarningsAccumulatedLosses2023-10-3105951279core:ShareCapital2022-10-3105951279core:SharePremium2022-10-3105951279core:RevaluationReserve2022-10-3105951279core:OtherReservesSubtotal2022-10-3105951279core:RetainedEarningsAccumulatedLosses2022-10-3105951279core:LandBuildings2023-10-3105951279core:PlantMachinery2023-10-3105951279core:Vehicles2023-10-3105951279core:FurnitureFittings2023-10-3105951279core:OfficeEquipment2023-10-3105951279core:NetGoodwill2023-10-3105951279core:IntangibleAssetsOtherThanGoodwill2023-10-3105951279core:ListedExchangeTraded2023-10-3105951279core:UnlistedNon-exchangeTraded2023-10-3105951279core:LandBuildings2022-10-3105951279core:PlantMachinery2022-10-3105951279core:Vehicles2022-10-3105951279core:FurnitureFittings2022-10-3105951279core:OfficeEquipment2022-10-3105951279core:NetGoodwill2022-10-3105951279core:IntangibleAssetsOtherThanGoodwill2022-10-3105951279core:ListedExchangeTraded2022-10-3105951279core:UnlistedNon-exchangeTraded2022-10-3105951279core:LandBuildings2022-11-012023-10-3105951279core:PlantMachinery2022-11-012023-10-3105951279core:Vehicles2022-11-012023-10-3105951279core:FurnitureFittings2022-11-012023-10-3105951279core:OfficeEquipment2022-11-012023-10-3105951279core:NetGoodwill2022-11-012023-10-3105951279core:IntangibleAssetsOtherThanGoodwill2022-11-012023-10-3105951279core:ListedExchangeTraded2022-11-012023-10-3105951279core:UnlistedNon-exchangeTraded2022-11-012023-10-3105951279core:MoreThanFiveYears2022-11-012023-10-3105951279core:Non-currentFinancialInstruments2023-10-3105951279core:Non-currentFinancialInstruments2022-10-3105951279dpl:CostSales2022-11-012023-10-3105951279dpl:DistributionCosts2022-11-012023-10-3105951279core:LandBuildings2022-11-012023-10-3105951279core:PlantMachinery2022-11-012023-10-3105951279core:Vehicles2022-11-012023-10-3105951279core:FurnitureFittings2022-11-012023-10-3105951279core:OfficeEquipment2022-11-012023-10-3105951279dpl:AdministrativeExpenses2022-11-012023-10-3105951279core:NetGoodwill2022-11-012023-10-3105951279core:IntangibleAssetsOtherThanGoodwill2022-11-012023-10-3105951279dpl:GroupUndertakings2022-11-012023-10-3105951279dpl:ParticipatingInterests2022-11-012023-10-3105951279dpl:GroupUndertakingscore:ListedExchangeTraded2022-11-012023-10-3105951279core:ListedExchangeTraded2022-11-012023-10-3105951279dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-11-012023-10-3105951279core:UnlistedNon-exchangeTraded2022-11-012023-10-3105951279dpl:CostSales2021-10-012022-10-3105951279dpl:DistributionCosts2021-10-012022-10-3105951279core:LandBuildings2021-10-012022-10-3105951279core:PlantMachinery2021-10-012022-10-3105951279core:Vehicles2021-10-012022-10-3105951279core:FurnitureFittings2021-10-012022-10-3105951279core:OfficeEquipment2021-10-012022-10-3105951279dpl:AdministrativeExpenses2021-10-012022-10-3105951279core:NetGoodwill2021-10-012022-10-3105951279core:IntangibleAssetsOtherThanGoodwill2021-10-012022-10-3105951279dpl:GroupUndertakings2021-10-012022-10-3105951279dpl:ParticipatingInterests2021-10-012022-10-3105951279dpl:GroupUndertakingscore:ListedExchangeTraded2021-10-012022-10-3105951279core:ListedExchangeTraded2021-10-012022-10-3105951279dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-10-012022-10-3105951279core:UnlistedNon-exchangeTraded2021-10-012022-10-3105951279core:NetGoodwill2023-10-3105951279core:IntangibleAssetsOtherThanGoodwill2023-10-3105951279core:LandBuildings2023-10-3105951279core:PlantMachinery2023-10-3105951279core:Vehicles2023-10-3105951279core:FurnitureFittings2023-10-3105951279core:OfficeEquipment2023-10-3105951279core:AfterOneYear2023-10-3105951279core:WithinOneYear2023-10-3105951279core:ListedExchangeTraded2023-10-3105951279core:UnlistedNon-exchangeTraded2023-10-3105951279core:ShareCapital2023-10-3105951279core:SharePremium2023-10-3105951279core:RevaluationReserve2023-10-3105951279core:OtherReservesSubtotal2023-10-3105951279core:RetainedEarningsAccumulatedLosses2023-10-3105951279core:NetGoodwill2022-10-3105951279core:IntangibleAssetsOtherThanGoodwill2022-10-3105951279core:LandBuildings2022-10-3105951279core:PlantMachinery2022-10-3105951279core:Vehicles2022-10-3105951279core:FurnitureFittings2022-10-3105951279core:OfficeEquipment2022-10-3105951279core:AfterOneYear2022-10-3105951279core:WithinOneYear2022-10-3105951279core:ListedExchangeTraded2022-10-3105951279core:UnlistedNon-exchangeTraded2022-10-3105951279core:ShareCapital2022-10-3105951279core:SharePremium2022-10-3105951279core:RevaluationReserve2022-10-3105951279core:OtherReservesSubtotal2022-10-3105951279core:RetainedEarningsAccumulatedLosses2022-10-3105951279core:NetGoodwill2021-10-0105951279core:IntangibleAssetsOtherThanGoodwill2021-10-0105951279core:LandBuildings2021-10-0105951279core:PlantMachinery2021-10-0105951279core:Vehicles2021-10-0105951279core:FurnitureFittings2021-10-0105951279core:OfficeEquipment2021-10-0105951279core:AfterOneYear2021-10-0105951279core:WithinOneYear2021-10-0105951279core:ListedExchangeTraded2021-10-0105951279core:UnlistedNon-exchangeTraded2021-10-0105951279core:ShareCapital2021-10-0105951279core:SharePremium2021-10-0105951279core:RevaluationReserve2021-10-0105951279core:OtherReservesSubtotal2021-10-0105951279core:RetainedEarningsAccumulatedLosses2021-10-0105951279core:AfterOneYear2022-11-012023-10-3105951279core:WithinOneYear2022-11-012023-10-3105951279core:Non-currentFinancialInstrumentscore:CostValuation2022-11-012023-10-3105951279core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-11-012023-10-3105951279core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-11-012023-10-3105951279core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-11-012023-10-3105951279core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-11-012023-10-3105951279core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-11-012023-10-3105951279core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-11-012023-10-3105951279core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-11-012023-10-3105951279core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-11-012023-10-3105951279core:Non-currentFinancialInstrumentscore:CostValuation2023-10-3105951279core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-10-3105951279core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-10-3105951279core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-10-3105951279core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-10-3105951279core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-10-3105951279core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-10-3105951279core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-10-3105951279core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-10-3105951279core:Non-currentFinancialInstrumentscore:CostValuation2022-10-3105951279core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-10-3105951279core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-10-3105951279core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-10-3105951279core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-10-3105951279core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-10-3105951279core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-10-3105951279core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-10-3105951279core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-10-3105951279bus:Director12022-11-012023-10-3105951279bus:Director22022-11-012023-10-3105951279bus:Director32022-11-012023-10-3105951279bus:Director42022-11-012023-10-3105951279core:FurnitureFittingsToolsEquipment2022-10-3105951279core:FurnitureFittingsToolsEquipment2022-11-012023-10-3105951279core:FurnitureFittingsToolsEquipment2023-10-31

GILCO CORPORATION LIMITED

Registered Number
05951279
(England and Wales)

Unaudited Financial Statements for the Year ended
31 October 2023

GILCO CORPORATION LIMITED
Company Information
for the year from 1 November 2022 to 31 October 2023

Directors

ANANDANAYAGAM, Sutharsan
PATEL, Arpit Jayeshkumar
PATEL, Axit
SUQLAIN, Sanaan

Registered Address

22 Page Street
London
SW1P 4EN

Registered Number

05951279 (England and Wales)
GILCO CORPORATION LIMITED
Balance Sheet as at
31 October 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets63,8973,923
3,8973,923
Current assets
Stocks834,75032,180
Debtors9144,130144,764
Cash at bank and on hand64,690112,001
243,570288,945
Creditors amounts falling due within one year10(279,671)(318,977)
Net current assets (liabilities)(36,101)(30,032)
Total assets less current liabilities(32,204)(26,109)
Creditors amounts falling due after one year11(10,000)(16,000)
Net assets(42,204)(42,109)
Capital and reserves
Called up share capital100100
Profit and loss account(42,304)(42,209)
Shareholders' funds(42,204)(42,109)
The financial statements were approved and authorised for issue by the Board of Directors on 27 July 2024, and are signed on its behalf by:
ANANDANAYAGAM, Sutharsan
Director
SUQLAIN, Sanaan
Director

Registered Company No. 05951279
GILCO CORPORATION LIMITED
Notes to the Financial Statements
for the year ended 31 October 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Principal activities
The principal activity of the company in the year under review was that of retail pharmacy.
4.Accounting policies
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Fixtures and fittings25
Stocks policy
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Revenue recognition policy
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation and operations policy
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Employee benefits policy
Contributions to defined contribution plans are expensed in the period to which they relate.
5.Employee information

20232022
Average number of employees during the year65
6.Property, plant and equipment

Fixtures & fittings

Total

££
Cost or valuation
At 01 November 2226,94426,944
Additions1,1751,175
At 31 October 2328,11928,119
Depreciation and impairment
At 01 November 2223,02123,021
Charge for year1,2011,201
At 31 October 2324,22224,222
Net book value
At 31 October 233,8973,897
At 31 October 223,9233,923
7.Description of nature of transactions and balances with related parties
At the yearend, the company owed £14,000 (2022:£50,468) to Shayona Healthcare Ltd which is the parent company of Gilco Corporation Limited.
8.Stocks

2023

2022

££
Finished goods34,75032,180
Total34,75032,180
9.Debtors

2023

2022

££
Trade debtors / trade receivables91,915121,959
Amounts owed by group undertakings14,000-
Other debtors30,34222,805
Prepayments and accrued income7,873-
Total144,130144,764
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
10.Creditors within one year

2023

2022

££
Trade creditors / trade payables116,410127,254
Bank borrowings and overdrafts6,0006,000
Amounts owed to related parties-50,468
Taxation and social security3,103664
Other creditors153,988134,421
Accrued liabilities and deferred income170170
Total279,671318,977
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
11.Creditors after one year

2023

2022

££
Bank borrowings and overdrafts10,00016,000
Total10,00016,000